Search clinical trials for: Combination 3 of radiofrequency (RF) power and Lesion Size Index (LSI) on left atrial (LA) posterior
Total 1 results
-
Oxford University Hospitals NHS TrustCompletedAtrial FibrillationUnited Kingdom
Sponsors and Collaborators
- Stefania Basili
- Donna Hammond, PhD
- Research Unit of General Practice, Odense
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Deutsche Arthrose-Hilfe
- RINO ZUID
- Alfred Hospital Intensive Care Unit Australia
- Jiajie Chen
- Canadian Hemophilia Society
- Shamir Optical Industry Ltd
- The First Affiliated Hospital of Air Force Medicial University
- InfraScan, Inc.
- University of Natural Resources and Life Sciences, Vienna, Austria
- Delosis Limited
- Centre Hospitalier de Bastia
- IDRI Corporation
- Prof. Jürgen Kuschyk, M.D
- Institute of Antibiotics, Huashan Hospital, Fudan University
- Faculdade de Medicina da Universidade do Porto (FMUP)
- Jikei University School of Medicine
- View Full List
Medical Conditions
- Colonic Adenoma
- Refractory Transformed B-Cell Non-Hodgkin Lymphoma
- Robot-assisted Laparoscopic Prostatectomy Under General Anesthesia
- Neovascular Age-related Macular Degeneration(nAMD)
- Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System
- Acute Myocardial Infarction, of Inferolateral Wall
- Open Reduction and Internal Fixation
- Ovarian Aging
- Insulin-Dependent Diabetes Mellitus
- UP in Online Group Format
- HIV Related Insulin Resistance
- Reduction, Weight
- Asian Consortium
- Surgery Induced Tissue Adhesions
- Subgluteal Sciatic Block
- Sensory Reconstruction of Digits
- Sepsis and Coagulopathy
- Incompetence, Functional
- Community-Acquired Staphylococcus Aureus
- Autosomal Dominant Hypocalcaemia
- View Full List
Drug Interventions
- Rosuvastatin calcium tablets
- LIS 18 U
- Atorvastatin, 10mg, 20mg, 40mg
- Epoetin beta (NeoRecormon®)
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- HLX23
- Gemcitabine (mg/m²)
- Prucalopride
- JR-141
- Domperidone
- Chlorcyclizine HCl
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- Radioligand (11C)AZD2184
- Moxifloxacin
- Sorafenib and OSI-906
- INCB7839
- Nanoliposomal Irinotecan
- Hypertonic saline
- Arm 1 - GEH120714 (18F) Injection
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Burundi
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Gabon
- Contract Research Organizations in Gambia
- Contract Research Organizations in India
- Contract Research Organizations in Italy
- Contract Research Organizations in Philippines
- Contract Research Organizations in South Korea
- Contract Research Organizations in Zimbabwe
- CRO list by country